Trials / Terminated
TerminatedNCT02554565
Innovation for Standard Identification of Insertional HPV Mutations and of Target Therapeutic Genes in Cervical Cancer: Towards Development of Personalized Biomarkers in Clinical Oncology (PAIR HPV)
Innovation for Standard Identification for Insertional HPV Mutations and of Target Therapeutic Genes in Cervical Cance: Towards Development of Personalized Biomarkers in Clinical Oncology (PAIR HPV : Human PapillomaVirus)
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 26 (actual)
- Sponsor
- Institut Curie · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Quantification and follow-up of circulating tumoral DNA in serum and/or plasma of patients with cervical cancer compared to the early detection of minimal metastatic disease.
Detailed description
Quantification and follow-up of circulating tumoral DNA in serum and/or plasma of patients with cervical cancer compared to the early detection of minimal metastatic disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Tumor biopsy | Tumor biopsy before treatment |
| PROCEDURE | Blood sampling | Blood sample before, during and after treatment |
Timeline
- Start date
- 2014-07-29
- Primary completion
- 2018-09-27
- Completion
- 2018-09-27
- First posted
- 2015-09-18
- Last updated
- 2025-09-08
Locations
4 sites across 1 country: France
Source: ClinicalTrials.gov record NCT02554565. Inclusion in this directory is not an endorsement.